Show
Sort by
-
- Journal Article
- A1
- open access
Does the impact of COVID‐19 on patients with systemic sclerosis change over time?
-
Cohort enrichment strategies for progressive interstitial lung disease in systemic sclerosis From European Scleroderma Trials and Research
-
Use of platelet inhibitors for digital ulcers related to systemic sclerosis : EUSTAR study on derivation and validation of the DU-VASC model
-
Cutaneous manifestations, clinical characteristics, and prognosis of patients with systemic sclerosis sine scleroderma : data from the International EUSTAR Database
-
Late skin fibrosis in systemic sclerosis : a study from the EUSTAR cohort
-
Sex influence on outcomes of patients with systemic sclerosis–associated interstitial lung disease : a EUSTAR database analysis
-
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database : analysis by region
-
Glucocorticoids prescribing practices in systemic sclerosis : an analysis of the EUSTAR database
-
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
-
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies : data from the EUSTAR cohort
-
- Journal Article
- A1
- open access
The burden of systemic sclerosis in Switzerland : the Swiss systemic sclerosis EUSTAR cohort
-
Tocilizumab in systemic sclerosis : a randomised, double-blind, placebo-controlled, phase 3 trial
-
Racial differences in systemic sclerosis disease presentation : a European Scleroderma Trials and Research group study
-
- Journal Article
- A1
- open access
Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis : an analysis from the EUSTAR database
-
- Journal Article
- A1
- open access
Phenotypes determined by cluster analysis and their survival in the prospective European Scleroderma Trials and Research cohort of patients with systemic sclerosis
-
Brief report: Smoking in systemic sclerosis : a longitudinal European Scleroderma Trials and Research group study
-
Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study
-
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study
-
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis : a 10-year longitudinal study from the EUSTAR database
-
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: a EUSTAR exploratory study
-
- Journal Article
- A1
- open access
Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population
-
- Journal Article
- A1
- open access
Nailfold capillaroscopy in systemic sclerosis: data from the EULAR scleroderma trials and research (EUSTAR) database
-
- Journal Article
- A1
- open access
Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study
-
- Journal Article
- A1
- open access
The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis
-
- Journal Article
- A1
- open access
Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy
-
A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort
-
Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population
-
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus